MARAVAI LIFESCIENCES HOLDINGS, INC. 4

CFO Rajesh Asarpota had 5,465 MRVI Class A shares withheld for taxes upon RSU vesting, leaving him with 423,486 shares owned directly.

On August 31, 2026, Maravai Lifesciences Holdings, Inc. Chief Financial Officer Rajesh Asarpota had 5,465 shares of Class A Common Stock withheld by the company at an implied price of approximately $7.68 per share to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units, a routine non-open-market transaction that reduced his directly held shares to 423,486 with an estimated post-transaction value of about $3.25 million based on the indicated price.

Filing Facts

CIK

1823239

Ticker

MRVI

Form

4

Source Type

fda

Accession

0001600301-26-000006

Alert Tier

5